Moleculin Announces Positive Data for its Pancreatic Cancer Drug Candidate

World News: . []

HOUSTON Jan 03 2019 GLOBE NEWSWIRE -- LINK  Biotech Inc Nasdaq MBRX Moleculin or the LINK  a clinical stage pharmaceutical company LINK  on the development of oncology drug candidates all of which are based on license ag reement...

More news and information about Moleculin Biotech, Inc.

Published By:

Globe Newswire: 12:30 GMT Thursday 3rd January 2019

Published: .

Search for other references to "moleculin" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us